Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients

scientific article published in August 2001

Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1042487130
P356DOI10.1038/EYE.2001.167
P698PubMed publication ID11767031
P5875ResearchGate publication ID11590843

P2093author name stringCooper M
Chowers I
Granot E
Merin S
Banin E
P2860cites workRed blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosaQ72564966
The neuropathy of abetalipoproteinemiaQ72603694
Familial hypobetalipoproteinemia--differences in lipoprotein structure and compositionQ72780814
A-BETA-LIPOPROTEINAEMIA WITH SPECIAL REFERENCE TO THE VISUAL DEFECTQ78321154
Changes produced by light in the standing potential of the human eyeQ79336034
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemiaQ24294711
Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemiaQ28262033
Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemiaQ33645105
Bassen-Kornzweig syndrome. Present statusQ34633861
Long-term management of abetalipoproteinaemia. Possible role for vitamin EQ34989797
Hypocholesterolemia in childhoodQ38668950
Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemiaQ41830444
Abetalipoproteinaemia in adults: role of vitamin therapyQ43747702
Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiencyQ48350783
Ocular Motor Signs in Some Metabolic DiseasesQ50937666
VITAMIN E AND NEUROLOGICAL FUNCTIONQ56609576
Ophthalmoplegia and Dissociated Nystagmus in AbetalipoproteinemiaQ67447693
Electroretinographic Responses Following Vitamin A Therapy in A-Beta-LipoproteinemiaQ69090763
Angioid streaks associated with abetalipoproteinemia. Case reportQ69265925
Neutral lipids of plasma and adipose tissue in a-betalipo-proteinaemiaQ71519855
Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemiaQ72057191
Abnormal plasma lipids of patients with Retinitis pigmentosaQ72319269
P433issuePt 4
P921main subjectvitamin AQ18225
abetalipoproteinemiaQ319812
retinal degenerationQ3043268
P304page(s)525-530
P577publication date2001-08-01
P1433published inEyeQ10278937
P1476titleLong-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients
P478volume15

Reverse relations

cites work (P2860)
Q42152035A Male Infant with Abetalipoproteinemia: A Case Report from Iran.
Q38167282Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management
Q34574677Abetalipoproteinemia in Israel: evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient
Q21202911Abetalipoproteinemia: two case reports and literature review
Q35056603Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins
Q33634096Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration
Q33758267Cholesterol in the retina: the best is yet to come.
Q42243027Clinical utility gene card for: Abetalipoproteinaemia
Q36695239Clinical utility gene card for: Abetalipoproteinaemia--Update 2014.
Q42243035Clinical utility gene card for: Familial Hypobetalipoproteinaemia (APOB).
Q36695217Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014.
Q37712100Clinical, hematological, and imaging observations in a 25-year-old woman with abetalipoproteinemia
Q36711327Common and rare gene variants affecting plasma LDL cholesterol
Q33587865Dosage and formulation issues: oral vitamin E therapy in children
Q39213724EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.
Q36217421Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review.
Q90320486Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease
Q37169928Establishment of reference values of α-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia
Q50334933Familial hypobetalipoproteinemia
Q36098448Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis
Q46208202Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases
Q38267212Insights from human congenital disorders of intestinal lipid metabolism
Q50514445Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up.
Q36359516Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism
Q34682702Ophthaproblem. Vitamin A and vitamin E.
Q40470219Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy.
Q57826004Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Q35570546The eye in metabolic disease
Q36787937The oil spill in ageing Bruch membrane
Q38208223Update on primary hypobetalipoproteinemia